Does prophylactic substrate-based catheter ablation reduce the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death?
Patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death
Prophylactic substrate-based catheter ablation
Incidence of ICD therapy
Prophylactic substrate-based catheter ablation reduces the incidence of ICD therapy in patients with prior MI receiving ICDs for secondary prevention.
In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 controlled-trials.com.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Vivek Y. Reddy
Electrophysiology
Matthew R. Reynolds
Electrophysiology
Petr Neužil
Electrophysiology
New England Journal of Medicine
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Na Homolce Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Reddy et al. (Wed,) studied this question.
synapsesocial.com/papers/69dea73b4838c5c0bab0c82b — DOI: https://doi.org/10.1056/nejmoa065457